Clinical Trials Directory

Trials / Completed

CompletedNCT03906383

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
20 Years – 31 Years
Healthy volunteers
Not accepted

Summary

Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal ischemic diseases. The purpose of the present study is to examine if the autoregulation of retinal vessel diameters in diabetic patients change after remote ischemic conditioning and if the observations are different from what have been observed in normal persons.

Conditions

Interventions

TypeNameDescription
OTHERRemote Ischemic ConditioningBrief reversible restriction of blood flow to upper limb in four cycles of 5 minutes of inflation at 200mm Hg followed by 5 minutes of deflation.

Timeline

Start date
2017-11-21
Primary completion
2018-10-16
Completion
2018-10-16
First posted
2019-04-08
Last updated
2019-04-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03906383. Inclusion in this directory is not an endorsement.

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes (NCT03906383) · Clinical Trials Directory